MacroGenics, Inc.
MGNX
$1.40
-$0.02-1.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 227.50% | 68.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 227.50% | 68.59% | |||
| Cost of Revenue | -10.86% | 10.20% | |||
| Gross Profit | 203.95% | 13.95% | |||
| SG&A Expenses | 6.48% | -13.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.13% | 5.70% | |||
| Operating Income | 150.70% | 13.76% | |||
| Income Before Tax | 146.54% | 11.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 146.40% | 11.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 146.40% | 11.66% | |||
| EBIT | 150.70% | 13.76% | |||
| EBITDA | 158.61% | 14.69% | |||
| EPS Basic | 146.33% | 11.89% | |||
| Normalized Basic EPS | 146.48% | 12.15% | |||
| EPS Diluted | 146.33% | 11.89% | |||
| Normalized Diluted EPS | 146.42% | 12.15% | |||
| Average Basic Shares Outstanding | 0.15% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.23% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||